(Total Views: 299)
Posted On: 08/08/2018 6:02:09 PM
Post# of 271
NetworkNewsBreaks – GTX Corp’s (GTXO) GPS SmartSole & Tracking Technology Selected by George Mason University Grant for Wandering Prediction Research
GPS technology-focused holding company GTX Corp (OTC: GTXO) this morning announced that George Mason University’s College of Health and Human Services (“Mason”) has selected the GTX Corp flagship GPS SmartSole and tracking technology platform to conduct its machine learning wandering prediction research. Mason has received a grant from the Alzheimer’s & Related Diseases Research Award Fund to continue its research, which is the first study to link movement patterns to the progression of Alzheimer’s disease (“AD”). “This is so remarkable and truly innovative thinking,” GTX Corp CEO Patrick Bertagna stated in the news release. “We began supporting Mason in 2016, with their first small and no budget study, and to see this work evolve to this degree is really impressive. Knowing that our technology continues to prove out its efficacy in what could potentially help millions of seniors afflicted with dementia is such a validation to our core mission statement. We are humbled and very proud to play a small roll in Professor Wojtusiak’s incredible forward-thinking and game-changing research.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
GPS technology-focused holding company GTX Corp (OTC: GTXO) this morning announced that George Mason University’s College of Health and Human Services (“Mason”) has selected the GTX Corp flagship GPS SmartSole and tracking technology platform to conduct its machine learning wandering prediction research. Mason has received a grant from the Alzheimer’s & Related Diseases Research Award Fund to continue its research, which is the first study to link movement patterns to the progression of Alzheimer’s disease (“AD”). “This is so remarkable and truly innovative thinking,” GTX Corp CEO Patrick Bertagna stated in the news release. “We began supporting Mason in 2016, with their first small and no budget study, and to see this work evolve to this degree is really impressive. Knowing that our technology continues to prove out its efficacy in what could potentially help millions of seniors afflicted with dementia is such a validation to our core mission statement. We are humbled and very proud to play a small roll in Professor Wojtusiak’s incredible forward-thinking and game-changing research.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
